Developing a tool to assess opioid risk in community pharmacies
Adaption and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool (PharmTool)
NA · University of Utah · NCT05706311
This study is testing a new tool to help pharmacists identify and reduce the risks of opioid use for patients getting prescriptions at community pharmacies.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Sex | All |
| Sponsor | University of Utah (other) |
| Locations | 2 sites (Cincinnati, Ohio and 1 other locations) |
| Trial ID | NCT05706311 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop and test the Opioid Risk Reduction Clinical Decision Support (ORRCDS) tool, which will serve as a risk screener and decision support platform for pharmacists dispensing prescription opioids. The study will involve randomizing pharmacies to either use the ORRCDS tool or continue with standard care to evaluate its effectiveness in reducing patients' opioid risk status. By leveraging community pharmacies, the study seeks to engage patients in discussions about opioid use and improve clinical decision-making based on evidence. The research will also explore the facilitators and barriers to the tool's sustainability and broader dissemination.
Who should consider this trial
Good fit: Ideal candidates for this study are patients receiving opioid prescriptions from participating community pharmacies in the Cincinnati or Columbus, Ohio area.
Not a fit: Patients who do not use opioids or are not receiving prescriptions from the participating pharmacies may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly reduce the risk of opioid misuse among patients receiving prescriptions.
How similar studies have performed: Other studies have shown promise in using clinical decision support tools for opioid risk assessment, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A large chain retail pharmacy chain in the Cincinnati or Columbus, Ohio area Exclusion Criteria: * None This study does not involve individual patients as randomization will occur among pharmacies.
Where this trial is running
Cincinnati, Ohio and 1 other locations
- University of Cincinnati — Cincinnati, Ohio, United States (RECRUITING)
- University of Utah — Salt Lake City, Utah, United States (RECRUITING)
Study contacts
- Principal investigator: Jerry Cochran, PhD — Associate Professor
- Study coordinator: Jerry Cochran, PhD
- Email: jerry.cochran@hsc.utah.edu
- Phone: 801-213-0654
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Opioid Abuse, Prescription Opioid Abuse